Welcome to LookChem.com Sign In|Join Free

CAS

  • or
BOC-TYR(ET)-OH is a chemical compound that features a tyrosine molecule with an ethyl (ET) functional group attached to its side chain. The BOC (tert-butyloxycarbonyl) group at the N-terminus of the molecule acts as a protective group for the amino group of tyrosine, preventing unwanted reactions. BOC-TYR(ET)-OH is primarily utilized in the synthesis of peptides, where the BOC group can be removed under mild acidic conditions to allow for further coupling and modification of the tyrosine residue in peptides and proteins.

76757-91-0

Post Buying Request

76757-91-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

76757-91-0 Usage

Uses

Used in Pharmaceutical Industry:
BOC-TYR(ET)-OH is used as a building block in the synthesis of bioactive peptides for various therapeutic applications. Its protective BOC group ensures that the tyrosine side chain remains unreactive during the initial stages of peptide assembly, facilitating the creation of complex peptide structures with specific biological functions.
Used in Research and Development:
In the field of research, BOC-TYR(ET)-OH is employed as a reagent for studying the role of tyrosine residues in protein-protein interactions and enzymatic activities. The controlled removal of the BOC group allows researchers to investigate the effects of tyrosine modifications on protein function and stability.
Used in Chemical Synthesis:
BOC-TYR(ET)-OH is utilized in the chemical synthesis of various compounds, including pharmaceuticals, agrochemicals, and specialty chemicals. The presence of the BOC group and the ethyl functional group on the tyrosine side chain provides opportunities for selective reactions and the creation of novel chemical entities with unique properties.
Used in Peptide Drug Development:
BOC-TYR(ET)-OH is used as a key intermediate in the development of peptide-based drugs. BOC-TYR(ET)-OH's ability to be selectively deprotected and modified allows for the design of peptides with enhanced stability, bioavailability, and therapeutic efficacy.

Check Digit Verification of cas no

The CAS Registry Mumber 76757-91-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,7,5 and 7 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 76757-91:
(7*7)+(6*6)+(5*7)+(4*5)+(3*7)+(2*9)+(1*1)=180
180 % 10 = 0
So 76757-91-0 is a valid CAS Registry Number.
InChI:InChI=1/C16H23NO5/c1-5-21-12-8-6-11(7-9-12)10-13(14(18)19)17-15(20)22-16(2,3)4/h6-9,13H,5,10H2,1-4H3,(H,17,20)(H,18,19)/t13-/m0/s1

76757-91-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-3-(4-ethoxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid

1.2 Other means of identification

Product number -
Other names t-Boc-L-tyrosine ethyl ether

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:76757-91-0 SDS

76757-91-0Relevant articles and documents

NOVEL PROCESS FOR THE PREPARATION OF GADOLINIUM COMPLEX OF (4S)-4-(4-ETHOXYBENZYL)-3,6,9-TRIS(CARBOXYLATOMETHYL)-3,6,9- TRIAZAUNDECANEDIOIC ACID DISODIUM (GADOXETATE DISODIUM)

-

, (2018/01/17)

The present invention discloses a novel process for the preparation of gadolinium complex of (4S)-4-(4-Ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9- triazaundecanedioic acid disodium of formula 1 and novel intermediates thereof.

Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1H-indene-5-carboxamide

-

, (2008/06/13)

The present invention is a process, including intermediates, to produce (2S)-2-dipropylamino)-6-ethoxy-2,3-dihydro-1H-indene-5-carboxamide which is a useful pharmaceutical agent.

Studies on analgesic oligopeptides. II. Structure-activity relationship among thirty analogs of a cyclic dipeptide, cyclo(-Tyr-Arg-)

Sasaki,Akutsu,Matsui,Suzuki,Sakurada,Sato,Kisara

, p. 4435 - 4443 (2007/10/02)

Thirty diketopiperazines were synthesized as analogs of cyclo(-Tyr-Arg-). The analgesic activities of these analogs were evaluated after intracerebral administration in mice. In the cyclo(-X-Arg-) series of analogs, cyclo[-Tyr(Et)-Arg-] showed the most po

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 76757-91-0